DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR BUPRENEX
» See Plans and Pricing
All Clinical Trials for Buprenex
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01324544 | Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain | Withdrawn | Purdue Pharma LP | Phase 3 | 2011-11-01 | The purpose of this study is to characterize the safety, pharmacokinetics (PK), and efficacy of intravenous (IV) buprenorphine in pediatric patients. |
NCT01407575 | Buprenorphine for Treatment Resistant Depression | Completed | National Alliance for Research on Schizophrenia and Depression | Phase 3 | 2011-09-01 | The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD). |
NCT01407575 | Buprenorphine for Treatment Resistant Depression | Completed | University of Pittsburgh | Phase 3 | 2011-09-01 | The purpose of this study is to compare the safety and efficacy of buprenorphine with placebo for adults with treatment resistant depression (TRD). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Buprenex
Condition Name
Clinical Trial Locations for Buprenex
Trials by Country
Clinical Trial Progress for Buprenex
Clinical Trial Phase
Clinical Trial Sponsors for Buprenex
Sponsor Name